ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
2 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
0 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Jakolu
|
1.0K |
305K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
1.0K
|
305K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Diamond’s last day at ANP
|
|
Jakolu
|
50 |
11K |
0 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
50
|
11K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Jakolu
|
99 |
28K |
2 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
99
|
28K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Chief Executive Officer and Managing Director Appointment
|
|
Jakolu
|
107 |
28K |
26 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
107
|
28K
|
26
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Jakolu
|
1.0K |
305K |
1 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
1.0K
|
305K
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Jakolu
|
1.0K |
305K |
1 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
1.0K
|
305K
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
Jakolu
|
1.0K |
305K |
9 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
1.0K
|
305K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive outcomes in DMD combination therapy animal study
|
|
Jakolu
|
124 |
37K |
6 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
124
|
37K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive outcomes in DMD combination therapy animal study
|
|
Jakolu
|
124 |
37K |
2 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
124
|
37K
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
28 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
28
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
5 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics CEO announces retirement
|
|
Jakolu
|
204 |
68K |
5 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
204
|
68K
|
5
|
|
ASX - By Stock
|
PER |
Re:
ANP - Interesting general news items in BIO
|
|
Jakolu
|
125 |
38K |
0 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
125
|
38K
|
0
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
Jakolu
|
328 |
91K |
9 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
328
|
91K
|
9
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
Jakolu
|
328 |
91K |
0 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
328
|
91K
|
0
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
Jakolu
|
328 |
91K |
5 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
328
|
91K
|
5
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
Jakolu
|
328 |
91K |
7 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
328
|
91K
|
7
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
10 |
06/09/22 |
06/09/22 |
Charts
|
5.9K
|
2.3M
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Full Year Statutory Accounts
|
|
Jakolu
|
150 |
48K |
1 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
150
|
48K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Full Year Statutory Accounts
|
|
Jakolu
|
150 |
48K |
5 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
150
|
48K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Full Year Statutory Accounts
|
|
Jakolu
|
150 |
48K |
10 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
150
|
48K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Ceasing to be a substantial holder
|
|
Jakolu
|
74 |
24K |
14 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
74
|
24K
|
14
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
5 |
23/08/22 |
23/08/22 |
Charts
|
5.9K
|
2.3M
|
5
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
13 |
23/08/22 |
23/08/22 |
Charts
|
5.9K
|
2.3M
|
13
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
19 |
23/08/22 |
23/08/22 |
Charts
|
5.9K
|
2.3M
|
19
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
Jakolu
|
228 |
86K |
1 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
228
|
86K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
Jakolu
|
228 |
86K |
11 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
228
|
86K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Jakolu
|
109 |
41K |
1 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
109
|
41K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Jakolu
|
109 |
41K |
5 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Jakolu
|
109 |
41K |
0 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
109
|
41K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Jakolu
|
109 |
41K |
1 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
109
|
41K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Jakolu
|
168 |
64K |
14 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
168
|
64K
|
14
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
3 |
08/08/22 |
08/08/22 |
Charts
|
5.9K
|
2.3M
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
5 |
05/08/22 |
05/08/22 |
Charts
|
5.9K
|
2.3M
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Investor Presentation
|
|
Jakolu
|
30 |
10K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Jakolu
|
31 |
7.8K |
13 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
31
|
7.8K
|
13
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
10 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
10
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
5 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
13 |
21/07/22 |
21/07/22 |
Charts
|
5.9K
|
2.3M
|
13
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
2 |
19/07/22 |
19/07/22 |
Charts
|
5.9K
|
2.3M
|
2
|
|
Charts
|
PER |
Re:
Chart
|
|
Jakolu
|
5.9K |
2.3M |
8 |
07/07/22 |
07/07/22 |
Charts
|
5.9K
|
2.3M
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
4 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
Jakolu
|
88 |
22K |
3 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
88
|
22K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
Jakolu
|
88 |
22K |
7 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
88
|
22K
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
0 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
Jakolu
|
86 |
23K |
0 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
86
|
23K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
|
|
Jakolu
|
86 |
23K |
4 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
86
|
23K
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Jakolu
|
3.5K |
1.0M |
1 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|